| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 07/09/2008 | CN101218224A Compounds and methods for the treatment or prevention of flavivirus infections |
| 07/09/2008 | CN101218206A Histamine H3 receptor antagonists |
| 07/09/2008 | CN101217957A 2,3 substituted pyrazine sulfonamides as inhibitors of CRTH2 |
| 07/09/2008 | CN101217954A Substituted oxazole derivatives and their use as tyrosine kinase inhibitors |
| 07/09/2008 | CN100400519C N-(substituted arylmethyl)-4-(disubstituted methyl)piperidines and piperazines |
| 07/09/2008 | CN100400518C Phthalazinone derivatives |
| 07/09/2008 | CN100400513C Phenylalanine enamide derivatives |
| 07/09/2008 | CN100400511C Cathepsin S inhibitors |
| 07/09/2008 | CN100400487C Glucocorticoid receptor modulators |
| 07/09/2008 | CN100400040C Tripeptidyl peptidase inhibitors |
| 07/08/2008 | US7396944 Thiophene derivatives, their manufacture and use as pharmaceutical agents |
| 07/08/2008 | US7396935 p38 kinase inhibitors; inflammatory bowel disease, rheumatoid arthritis, psoriasis, multiple sclerosis, endotoxin shock, osteoporosis, Alzheimer's disease, and congestive heart failure |
| 07/08/2008 | US7396848 oxazole derivatives to treat diabetic neuropathy and/or other kinds of peripheral neuropathy; 4-(4-chlorophenyl)-5-[3-(2-methoxyphenoxy)propyl]-2-(2-methyl-1-imidazolyl)oxazole |
| 07/08/2008 | US7396847 Oxazolidinone and/or isoxazoline as antibacterial agents |
| 07/08/2008 | US7396840 Chemokine receptor binding heterocyclic compounds |
| 07/08/2008 | US7396838 antitumor, anticarcinogenic agents; cytotoxic activity and angiogensis inhibitors; leukemia, colorectal cancer; orally |
| 07/08/2008 | US7396831 Vanilloid receptor ligands and their use in treatments |
| 07/08/2008 | US7396828 PI-3 kinase inhibitor prodrugs |
| 07/08/2008 | CA2432131C Pyrazole compounds useful as protein kinase inhibitors |
| 07/08/2008 | CA2387134C Cyclopropanes as cgrp antagonists, medicaments containing said compounds and method for the production thereof |
| 07/03/2008 | WO2008079907A1 Compositions and methods for inhibition of the jak pathway |
| 07/03/2008 | WO2008079316A1 Tetrahydroquinolinones, tetrahydronaphthyridones and derivatives thereof |
| 07/03/2008 | WO2008079277A1 Certain pyrazoline derivatives with kinase inhibitory activity |
| 07/03/2008 | WO2008079073A1 Indazolyl sulphonamide derivatives for the treatment of glucocorticoid receptor mediated disorders |
| 07/03/2008 | WO2008078837A1 2-substituted-6-heterocyclic pyrimidone derivatives as tau protein kinase 1 inhbitors |
| 07/03/2008 | WO2008077404A1 Substituted acetophenones useful as pde4 inhibitors |
| 07/03/2008 | WO2008049919A3 Rho kinase inhibitors |
| 07/03/2008 | WO2008024980A3 Pyrrole, thiophene, furan, imidazole, oxazole, and thiazole derivatives |
| 07/03/2008 | WO2008002956A3 Thiazoline and oxazoline derivatives and their methods of use |
| 07/03/2008 | WO2007137417A8 Heterocyclic compounds as calcium channel blockers |
| 07/03/2008 | WO2003068170A3 Enzyme treatment of foodstuffs for celiac sprue |
| 07/03/2008 | US20080161581 Synthetic methodology for the reductive alkylation at the c-3 position of indoles |
| 07/03/2008 | US20080161580 Protected 3,5-dihydroxy-2,2-dimethyl-valeroamides for the synthesis of epothilones and derivatives and process for the production and the use |
| 07/03/2008 | US20080161374 Pyrazole compounds and uses related thereto |
| 07/03/2008 | US20080161330 e.g. 5-chloro-2-{4-methoxy-2-[3-(pyrid-2-yl)isoxazol-5-yl]pyrrolidin-1-yl}-4-(5-methyl-1H-pyrazol-3-ylamino)pyrimidine; insulin-like growth factor (somatomedin) antagonist; antiproliferation, anticarcinogenic, antitumor agent |
| 07/03/2008 | US20080161325 e.g. N1-[3-amino-4-(3,5-difluorophenyl)-2-hydroxybutyl]-3-(butylsulfonyl)-N1-(3-ethylbenzyl)-D-alaninamide dihydrochloride; inhibitors of amyloid beta-secretase enzyme; neurodegenerative diseases: Alzheimer's, Parkinson's diseases, Down's syndrome |
| 07/03/2008 | US20080161322 e.g. 1-[2-tert-Butyl-6-(trifluoromethyl)pyrimidin-4-yl]-4-[3-(2-oxo-3,4-dihydroquinolin-1(2H)-yl)propyl]piperazin-4-ium chloride3,4-Dihydroquinolin-2(1H)-one; dopamine D3 receptor antagonists or agonists; antidepressant, schizophrenia, Parkinson's disease |
| 07/03/2008 | US20080161310 (2S)-4,4-difluoro-1-(2-{[1-(2-pyrazinyl)piperidin-4-yl]amino}acetyl)-2-pyrrolidine carbonitrile; enzyme inhibitors; diabetes |
| 07/03/2008 | US20080161309 Novel Compounds |
| 07/03/2008 | US20080161306 Pyrrole Derivatives as Dna Gyrase and Topoisomerase Inhibitors |
| 07/03/2008 | US20080161305 C-Met Modulators and Methods of Use |
| 07/03/2008 | US20080161301 2-Oxy-Benzoxazinone Derivatives for the Treatment of Obesity |
| 07/03/2008 | US20080161280 Inhibitors of poly(adp-ribose)polymerase |
| 07/03/2008 | CA2674557A1 2-substituted-6-heterocyclic pyrimidone derivatives |
| 07/03/2008 | CA2673370A1 Substituted acetophenones useful as pde4 inhibitors |
| 07/03/2008 | CA2673003A1 Quinazolines for pdk1 inhibition |
| 07/02/2008 | WO2007087518A2 2-substituted benzimidazoles as selective androgen receptor modulators (sarms) |
| 07/02/2008 | EP1939189A1 Derivative having ppar agonistic activity |
| 07/02/2008 | EP1939188A1 Oxa-and thiazole derivatives useful as antidiabetic and antiobesity agents |
| 07/02/2008 | EP1939181A1 Heteroaryl-substituted carboxamides and use thereof for the stimulation of the expression of NO synthase |
| 07/02/2008 | EP1939180A1 Heteroarylacrylamides and their use as pharmaceuticals for the stimulation of the expression of endothelial NO synthase |
| 07/02/2008 | EP1937674A1 Isoxazole derivatives |
| 07/02/2008 | EP1937673A1 Imidazole derivatives as inhibitors of tafia |
| 07/02/2008 | EP1937669A1 Novel benzopyran derivatives as potassium channel openers |
| 07/02/2008 | EP1937666A1 Substituted heterocyclic compounds with cxcr3 antagonist activity |
| 07/02/2008 | EP1937664A1 Hydrazide compound and pesticidal use of the same |
| 07/02/2008 | EP1937652A1 Pyrimidine amide compounds as pgds inhibitors |
| 07/02/2008 | EP1646626B1 Pyrrole-2, 5-dione derivatives as liver x receptor modulators |
| 07/02/2008 | EP1633745B1 Aroyl semicarbazide derivatives against thromboembolic diseases |
| 07/02/2008 | EP1501808B1 Tachykinin receptor antagonists |
| 07/02/2008 | EP1496838A4 Substituted amides |
| 07/02/2008 | CN101213195A Substituted glycinamides having an antithrombotic and factor xa-inhibiting effect |
| 07/02/2008 | CN101213192A Pyrimidine-substituted benzimidazole derivatives as protein kinase inhibitors |
| 07/02/2008 | CN101213190A Compounds and compositions as TPO mimetics |
| 07/02/2008 | CN101213187A Isoquinoline derivatives as inhibitors of RHO-kinase |
| 07/02/2008 | CN101213185A Pyridyl and phenyl substituted piperazine-piperidines with CXCR3 antagonist activity |
| 07/02/2008 | CN101212969A Azinone and diazinone V3 inhibitors for depression and stress disorders |
| 07/02/2008 | CN100398537C Cycloalkyl derivatives having bioisosteric carboxylic acid groups, processes for their preparation and their use as pharmaceuticals |
| 07/02/2008 | CN100398536C Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide |
| 07/02/2008 | CN100398535C Piperidine derivatives and their use as modulators of chemokine receptor activity especially CCR5 |
| 07/02/2008 | CN100398526C 3-methyl-2- (3- (2-phenyl-oxazol-4-ylmethoxy)-cyclohexanecarbonyl-amino butyric acid derivatives and related compounds as ppar modulators for the treatment of type 2 diabetes and atherosclerosis |
| 07/02/2008 | CN100398522C Inhibitors of cathepsin S |
| 07/02/2008 | CN100398107C Use of IkappaB-kinase inhibitors in preparing medicament for pain therapy |
| 07/02/2008 | CN100398105C 1,3-substitued cycloalkyl derivatives having acidic, mostly heterocyclic groups, processes for their preparation and their use as pharmaceuticals |
| 07/02/2008 | CA2640046A1 2-substituted benzimidazoles as selective androgen receptor modulators (sarms) |
| 07/01/2008 | US7393960 peroxisome proliferator activated receptor agonist such as (2R)-2-(3-{[3-(4-chlorophenoxy)-2-methyl-6-(trifluoromethoxy)-1H-indol-1-yl]methyl}phenoxy)butanoic acid, used for treatment and control of metabilic disorders |
| 07/01/2008 | US7393957 Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments |
| 07/01/2008 | US7393955 Synthesis and use of tetracyclic benzamide derivatives; antidiabetic agents; coupling isochromene anhydride with cyanobenzene compound and performing ring substitution reactions |
| 07/01/2008 | US7393873 Arylsulfonamide derivatives |
| 07/01/2008 | US7393870 3-(heteroarylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 07/01/2008 | US7393866 Anticholesterol agents; antilipemic agents; cardiovascular disorders; antiischemic agents; anticancer agents |
| 07/01/2008 | US7393852 analgesics; antiinflammatory agents; antiarthritic agents;Alzheimer's disease; cirrhosis; antiallergens; antihistamines ; anticancer agents; vision defects |
| 07/01/2008 | US7393845 2-{2-[4-(2,3-Dihydrobenzo[1,4]dioxin-5-yl)piperazin-1-yl]ethylsulfanyl}-6-methylnicotinonitrile; serotonin and dopamine receptor antagonist, serotonin reuptake inhibitor; anxiolytic agent, antidepressant; panic and obsessive compulsive disorder, social phobia, eating disorders, psychosis |
| 07/01/2008 | US7393844 Tetrahydropyranyl cyclopentyl heterocyclic amide modulators of chemokine receptor activity |
| 06/26/2008 | WO2008076862A2 1-substituted imidazole derivatives and their use as aldosterone synthase inhibitors |
| 06/26/2008 | WO2008076860A1 4-imidazolyl-1,2,3,4-tetrahydroquinoline derivatives and their use as aldosterone/11-beta-hydroxylase inhibitors |
| 06/26/2008 | WO2008076754A2 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity |
| 06/26/2008 | WO2008076685A2 Process for the preparation of piperazinyl and diazepanyl benzamide derivatives |
| 06/26/2008 | WO2008076048A1 Indazolyl ester and amide derivatives for the treatment of glucocorticoid receptor mediated disorders |
| 06/26/2008 | WO2008075735A1 Prophylactic or therapeutic agent for alopecia |
| 06/26/2008 | WO2008075070A1 Sulfonamide derivatives for therapeutic use as fatty acid synthase inhibitors |
| 06/26/2008 | WO2008075064A1 Piperidine derivatives for the treatment of obesity |
| 06/26/2008 | WO2008075019A1 Modulators of cb1 receptors |
| 06/26/2008 | WO2008074991A1 Novel herbicides |
| 06/26/2008 | WO2008074835A1 2-substituted 5-membered heterocycles as scd inhibitors |
| 06/26/2008 | WO2008074821A1 Indole derivatives as s1p1 receptor agonists |
| 06/26/2008 | WO2008074820A1 Oxadiazole derivatives as s1p1 receptor agonists |
| 06/26/2008 | WO2008074450A2 Non-peptidic renin inhibitors nitroderivatives |
| 06/26/2008 | WO2008074413A2 Heteroarylacrylamides and their use as pharmaceuticals for the stimulation of the expression of endothelial no synthase |
| 06/26/2008 | WO2008074068A1 Substituted quinoline derivatives as antiamyloidogeneic agents |